Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

RespireRx Pharmaceuticals Inc. (CORX) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues0.00.00.02.25.411.90.10.1
            Revenue growth  -100.0%-59.5%-54.4%13549.7%40.9%2998.8%
Cost of goods sold0.00.00.00.00.00.0-7.7-7.5
Gross profit0.00.00.02.25.411.97.77.6
            Gross margin   100.0%100.0%100.0%8905.0%12337.8%
Research and development0.70.60.60.71.53.21.70.6
General and administrative1.92.71.11.53.98.73.63.8
EBIT-2.6-3.3-1.7-2.2-4.2-8.5-5.2-4.4
            EBIT margin   -99.3%-78.5%-71.4%-6028.4%-7059.7%
Pre-tax income-3.1-4.3-2.1-2.6-4.3-9.2-6.0-2.7
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-3.5-5.7-2.1-2.6-4.3-9.2-6.0-12.8
            Net margin   -118.3%-79.3%-77.8%-6867.3%-20705.3%
 
Diluted EPS($0.04)($0.22)($5.41)($0.77)($1.77)($4.95)($5.05)($0.07)
Shares outstanding (diluted)88.325.90.43.42.41.91.2192.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy